These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 10838684

  • 1. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
    Arlt A, Luckhaupt H, Hildmann H.
    Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
    [Abstract] [Full Text] [Related]

  • 2. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E, Laçin M, Asal K, Ceylan A, Köybaşioğlu A, Ileri F, Uslu SS.
    Kulak Burun Bogaz Ihtis Derg; 2004 Apr; 12(1-2):23-30. PubMed ID: 16010093
    [Abstract] [Full Text] [Related]

  • 3. [The SCC antigen is not a reliable tumor marker in the ENT area. Value of squamous cell carcinoma antigen in diagnosis and follow-up of squamous epithelial carcinoma in the head-neck area. Results of a retrospective study over 6 years].
    Gotschuli A, Anderhuber W, Danninger R, Habermann W.
    Laryngorhinootologie; 1998 Mar; 77(3):165-7. PubMed ID: 9577824
    [Abstract] [Full Text] [Related]

  • 4. [Squamous cell carcinoma antigen. Current clinical value of a new tumor marker in head and neck cancer; preliminary results of a prospective study after 12 months].
    Clasen B, Roettger D, Senekowitsch R, Menz E.
    Laryngol Rhinol Otol (Stuttg); 1988 Aug; 67(8):420-5. PubMed ID: 3210877
    [Abstract] [Full Text] [Related]

  • 5. [Squamous cell carcinoma-associated antigen (SCC) as a tumor marker in the initial diagnosis of carcinomas of the head and neck region. Results of a prospective study after 24 months].
    Clasen B, Péré P, Senekowitsch R, Menz E.
    Laryngorhinootologie; 1990 May; 69(5):275-80. PubMed ID: 2191678
    [Abstract] [Full Text] [Related]

  • 6. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
    Eibling DE, Johnson JT, Wagner RL, Su S.
    Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
    [Abstract] [Full Text] [Related]

  • 7. [Relevance of the new tumor marker SCC (squamous cell carcinoma antigen) for the diagnosis and follow-up control of squamous epithelial carcinoma of the head and neck].
    Koch T, Eiffert H, Spindler MB.
    HNO; 1989 Nov; 37(11):454-9. PubMed ID: 2584067
    [Abstract] [Full Text] [Related]

  • 8. Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness.
    Forni F, Ferrandina G, Deodato F, Macchia G, Morganti AG, Smaniotto D, Luzi S, D'Agostino G, Valentini V, Cellini N, Giardina B, Scambia G.
    Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1145-9. PubMed ID: 17689030
    [Abstract] [Full Text] [Related]

  • 9. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck].
    Zöller J, Fiehn W, Mende U, Hotz G.
    Dtsch Z Mund Kiefer Gesichtschir; 1990 Nov 15; 14(4):254-9. PubMed ID: 2134649
    [Abstract] [Full Text] [Related]

  • 10. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L.
    Zhonghua Wai Ke Za Zhi; 1993 Mar 15; 31(3):143-5. PubMed ID: 8223022
    [Abstract] [Full Text] [Related]

  • 11. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
    Bolli JA, Doering DL, Bosscher JR, Day TG, Rao CV, Owens K, Kelly B, Goldsmith J.
    Gynecol Oncol; 1994 Nov 15; 55(2):169-73. PubMed ID: 7959279
    [Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
    Yoneda K, Hirota J, Yamamoto T, Ueta E, Osaki T.
    Gan No Rinsho; 1990 Mar 15; 36(4):458-64. PubMed ID: 2181163
    [Abstract] [Full Text] [Related]

  • 13. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N, van der Velden J, Ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AG.
    J Clin Oncol; 2005 Mar 01; 23(7):1455-62. PubMed ID: 15735121
    [Abstract] [Full Text] [Related]

  • 14. The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck.
    Micke O, Bruns F, Schäfer U, Horst E, Büntzel J, Willich N.
    Anticancer Res; 2003 Mar 01; 23(2A):907-11. PubMed ID: 12820321
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M, Tamura N, Kobayashi H, Ohwada M, Terao T, Sato I.
    Gynecol Oncol; 2000 Jun 01; 77(3):405-9. PubMed ID: 10831350
    [Abstract] [Full Text] [Related]

  • 16. [Tumor markers in patients with head-neck carcinomas].
    Walther EK, Dahlmann N, Gorgulla HT.
    Laryngorhinootologie; 1990 May 01; 69(5):271-4. PubMed ID: 2354022
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC.
    Molina R, Torres MD, Moragas M, Filella X, Jo J, Giménez N, Traserra J, Ballesta AM.
    Anticancer Res; 1995 May 01; 15(2):479-84. PubMed ID: 7763026
    [Abstract] [Full Text] [Related]

  • 18. [Quantitative changes in the immunoglobulin G subclass system--a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck].
    Anderhuber W, Steinschifter W, Gotschuli A, Schauenstein E, Schauenstein K.
    Laryngorhinootologie; 1998 Oct 01; 77(10):564-8. PubMed ID: 9842520
    [Abstract] [Full Text] [Related]

  • 19. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
    Geyer H, Schwörer D, Pfleiderer A.
    Geburtshilfe Frauenheilkd; 1989 Mar 01; 49(3):266-71. PubMed ID: 2721888
    [Abstract] [Full Text] [Related]

  • 20. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
    Crombach G, Würz H, Herrmann F, Kreienberg R, Möbus V, Schmidt-Rhode P, Sturm G, Caffier H, Kaesemann H.
    Dtsch Med Wochenschr; 1989 May 05; 114(18):700-5. PubMed ID: 2714197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.